234 related articles for article (PubMed ID: 33507119)
1. Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy.
Tse HN; Borrow R; Arkwright PD
Expert Rev Vaccines; 2020 Dec; 19(12):1115-1127. PubMed ID: 33507119
[No Abstract] [Full Text] [Related]
2. Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review.
Keller M; Pittet LF; Zimmermann P
Eur J Pediatr; 2022 Apr; 181(4):1329-1362. PubMed ID: 34936010
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents.
Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Arai K; Ito R; Kawai T; Ito S
PLoS One; 2020; 15(10):e0240217. PubMed ID: 33002085
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
[TBL] [Abstract][Full Text] [Related]
6. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
7. Advances in our understanding of immunization and vaccines for patients with systemic lupus erythematosus.
Bragazzi NL; Watad A; Sharif K; Adawi M; Aljadeff G; Amital H; Shoenfeld Y
Expert Rev Clin Immunol; 2017 Oct; 13(10):939-949. PubMed ID: 28749245
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.
Chanthavanich P; Limkittikul K; Sirivichayakul C; Chokejindachai W; Hattasingh W; Pengsaa K; Surangsrirat S; Srisuwannaporn T; Kaewma B; Yoksan S; Jun G; Zhumu B
Hum Vaccin Immunother; 2018 Apr; 14(4):900-905. PubMed ID: 29227177
[TBL] [Abstract][Full Text] [Related]
9. Vaccinations in juvenile chronic inflammatory diseases: an update.
Silva CA; Aikawa NE; Bonfa E
Nat Rev Rheumatol; 2013 Sep; 9(9):532-43. PubMed ID: 23820860
[TBL] [Abstract][Full Text] [Related]
10. Vaccination for Children on Biologics.
Toplak N; Uziel Y
Curr Rheumatol Rep; 2020 May; 22(7):26. PubMed ID: 32436130
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
Huang LM; Chiu CH; Chiu NC; Lin CY; Li MT; Kuo TY; Weng YJ; Hsieh EF; Tai IC
Vaccine; 2019 Mar; 37(13):1827-1835. PubMed ID: 30803843
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6 years and 2-35 months of age- an open-label, randomized phase IIb clinical trial.
Hung MC; Cho CY; Chen CJ; Lai CC; Wu KG
Vaccine; 2019 Sep; 37(37):5559-5566. PubMed ID: 31399275
[TBL] [Abstract][Full Text] [Related]
13. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
[TBL] [Abstract][Full Text] [Related]
14. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations.
Heijstek MW; Ott de Bruin LM; Borrow R; van der Klis F; Koné-Paut I; Fasth A; Minden K; Ravelli A; Abinun M; Pileggi G; Borte M; Bijl M; Wulffraat NM
Autoimmun Rev; 2011 Dec; 11(2):112-22. PubMed ID: 21896342
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
[TBL] [Abstract][Full Text] [Related]
16. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.
Keller-Stanislawski B; Englund JA; Kang G; Mangtani P; Neuzil K; Nohynek H; Pless R; Lambach P; Zuber P
Vaccine; 2014 Dec; 32(52):7057-64. PubMed ID: 25285883
[TBL] [Abstract][Full Text] [Related]
17. Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide.
Blanchard-Rohner G
Front Immunol; 2021; 12():711637. PubMed ID: 34408752
[TBL] [Abstract][Full Text] [Related]
18. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.
Van Damme P; De Coster I; Bandyopadhyay AS; Revets H; Withanage K; De Smedt P; Suykens L; Oberste MS; Weldon WC; Costa-Clemens SA; Clemens R; Modlin J; Weiner AJ; Macadam AJ; Andino R; Kew OM; Konopka-Anstadt JL; Burns CC; Konz J; Wahid R; Gast C
Lancet; 2019 Jul; 394(10193):148-158. PubMed ID: 31174831
[TBL] [Abstract][Full Text] [Related]
19. Japanese encephalitis vaccines.
Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
[No Abstract] [Full Text] [Related]
20. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
